Please login to the form below

Neupogen

This page shows the latest Neupogen news and features for those working in and with pharma, biotech and healthcare.

Novartis doubles down on biosimilars with Biocon alliance

Previous launches have included its Glatopa version of Teva’s multiple sclerosis drug Copaxone (glatiramer acetate) and Zarxio, a variant of Amgen’s Neupogen (filgrastim).

Latest news

Novartis takes biosimilar delay complaint to Supreme Court

Novartis is appealing an earlier ruling which ordered the company to delay launch of Zarxio, its version of Amgen's white blood cell stimulator Neupogen (filgrastim) and the first biosimilar to
Novartis claims first place for its biosimilar Enbrel in US

biosimilars business after the company got a green light for its Zarxio copy of Amgen's neutropenia therapy Neupogen (filgrastim).
Novartis gets FDA panel backing for biosimilar Enbrel

The GP2015 recommendation also puts Novartis on course for a second biosimilar approval in the US after its Zarxio product, a copy of Amgen's white blood cell stimulator Neupogen (filgrastim)
Sandoz files for approval of Neulasta biosimilar in Europe

The generic drug specialist - which also sells a biosimilar version of Amgen's short-acting GCSF product Neupogen (filgrastim) - said the Neulasta filing means it is now halfway to its objective
FDA panel recommends first biosimilar antibody for approval

The drug is also only the second biosimilar to be approved in the US after Novartis/Sandoz' Zarxio (filgrastim-sndz), which is a copy of Amgen's white cell stimulator Neupogen

More from news
Approximately 7 fully matching, plus 30 partially matching documents found.

Latest Intelligence

Biosimilars - the same, but different?

Neupogen (filgrastim).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

AP Pharma appoints Dendreon’s Jesse Hollingsworth to lead sales

This was preceded by a period as marketing director for the oncology business unit of Amgen, where he worked on such products as Neulasta, Neupogen and Vectibix.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Senior Medical Writer: Competitive salary and benefits

Senior Medical Writer: Salary TBC

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

PR Associate Director – Consumer Health & Beauty: Salary TBC

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Director – Healthcare PR: Salary TBC

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Editor – Medical Education Agency – Bucks: Salary TBC

Account Director, Medical Education: Salary TBC

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Subscribe to our email news alerts

PMHub

Add my company

Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...